Synapse

← Clinical & Translational Immunology

Papers in Clinical & Translational Immunology

Page 10 · newest first

  1. Narrowband UVB phototherapy reduces TNF production by B‐cell subsets stimulated via TLR7 from individuals with early multiple sclerosisClinical & Translational Immunology · 2020
  2. Emerging insights on the role of gasdermins in infection and inflammatory diseasesClinical & Translational Immunology · 2020
  3. Influenza‐specific IgG1+ memory B‐cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiencyClinical & Translational Immunology · 2020
  4. Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibodyClinical & Translational Immunology · 2020
  5. Tocilizumab monotherapy uncovered the role of the CCL22/17‐CCR4+ Treg axis during remission of crescentic glomerulonephritisClinical & Translational Immunology · 2020
  6. Immune microenvironment composition in non‐small cell lung cancer and its association with survivalClinical & Translational Immunology · 2020
  7. Risk stratification biomarkers for Staphylococcus aureus bacteraemiaClinical & Translational Immunology · 2020
  8. Mucins and their receptors in chronic lung diseaseClinical & Translational Immunology · 2020
  9. Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiencyClinical & Translational Immunology · 2020
  10. Limited effect of duration of CMV infection on adaptive immunity and frailty: insights from a 27‐year‐long longitudinal studyClinical & Translational Immunology · 2020
  11. Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody responseClinical & Translational Immunology · 2020
  12. Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cellsClinical & Translational Immunology · 2020
  13. Comparison of two human organoid models of lung and intestinal inflammation reveals Toll‐like receptor signalling activation and monocyte recruitmentClinical & Translational Immunology · 2020
  14. Pro‐inflammatory dopamine‐2 receptor‐specific T cells in paediatric movement and psychiatric disordersClinical & Translational Immunology · 2020
  15. Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancerClinical & Translational Immunology · 2020
  16. Frontiers in antiviral therapy and immunotherapyClinical & Translational Immunology · 2020
  17. Immunosuppression and cardiovascular dysfunction in patients with severe versus mild coronavirus disease 2019: a case seriesClinical & Translational Immunology · 2020
  18. Innate lymphoid cell composition associates with COVID‐19 disease severityClinical & Translational Immunology · 2020
  19. Dynamics of peripheral immune cells and their HLA‐G and receptor expressions in a patient suffering from critical COVID‐19 pneumonia to convalescenceClinical & Translational Immunology · 2020
  20. Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019Clinical & Translational Immunology · 2020
  21. Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19Clinical & Translational Immunology · 2020
  22. Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancerClinical & Translational Immunology · 2020
  23. Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumabClinical & Translational Immunology · 2020
  24. Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)Clinical & Translational Immunology · 2020
  25. Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cellsClinical & Translational Immunology · 2020
  26. Screening for primary immunodeficiency diseases by next‐generation sequencing in early lifeClinical & Translational Immunology · 2020
  27. Targeting Toll‐like receptor‐4 to tackle preterm birth and fetal inflammatory injuryClinical & Translational Immunology · 2020
  28. Interleukin (IL)‐33: an orchestrator of immunity from host defence to tissue homeostasisClinical & Translational Immunology · 2020
  29. Quantitative multiplex profiling of the complement system to diagnose complement‐mediated diseasesClinical & Translational Immunology · 2020
  30. Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort studyClinical & Translational Immunology · 2020
  31. Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysisClinical & Translational Immunology · 2020
  32. Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1‐specific CD8+ T cellsClinical & Translational Immunology · 2020
  33. A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathiesClinical & Translational Immunology · 2020
  34. Inhibition of interleukin‐1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritisClinical & Translational Immunology · 2020
  35. Development and characterisation of NKp44‐based chimeric antigen receptors that confer T cells with NK cell‐like specificityClinical & Translational Immunology · 2020
  36. Hypothesis: bipolar disorder is an Epstein–Barr virus‐driven chronic autoimmune disease – implications for immunotherapyClinical & Translational Immunology · 2020
  37. Machine learning applied to whole‐blood RNA‐sequencing data uncovers distinct subsets of patients with systemic lupus erythematosusClinical & Translational Immunology · 2019
  38. The complex existence of γδ T cells following transplantation: the good, the bad and the simply confusingClinical & Translational Immunology · 2019
  39. Translation of peptidoglycan metabolites into immunotherapeuticsClinical & Translational Immunology · 2019
  40. Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerationsClinical & Translational Immunology · 2019
  41. Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmissionClinical & Translational Immunology · 2019
  42. Switching on the green light for chimeric antigen receptor T‐cell therapyClinical & Translational Immunology · 2019
  43. Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastomaClinical & Translational Immunology · 2019
  44. In memoriam: Paul Fisch (1959–2018) our dear friend, pioneer of γδ T cell research, esteemed scientist, and dedicated clinicianClinical & Translational Immunology · 2019
  45. Crohn's disease is facilitated by a disturbance of programmed death‐1 ligand 2 on blood dendritic cellsClinical & Translational Immunology · 2019
  46. The clock is ticking: the impact of ageing on T cell metabolismClinical & Translational Immunology · 2019
  47. Tissue‐specific tumor microenvironments influence responses to immunotherapiesClinical & Translational Immunology · 2019
  48. Distinguishing naive‐ from memory‐derived human B cells during acute responsesClinical & Translational Immunology · 2019
  49. Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosisClinical & Translational Immunology · 2019
  50. The role and therapeutic implications of T cells in cancer of the lungClinical & Translational Immunology · 2019